Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model

Viral Immunology - Tập 22 Số 5 - Trang 309-319 - 2009
Jens Wild1, Kurt Bieler2, Josef Köstler1, Marie-Joëlle Frachette3, S. A. Jeffs4, S. Vieǐra4, Mariano Estéban5, Peter Liljeström6, G Pantaleo7, Hans Wolf1, Ralf Wagner2,1
1Institute of Medical Microbiology, University of Regensburg, Regensburg, Germany
2Geneart AG, Regensburg, Germany
3Sanofi Pasteur, Marcy-l'Étoile, France
4Section of Infectious Diseases, Division of Medicine, Faculty of Medicine, Imperial College, London, U.K.
5Department of Molecular and Cellular Biology, Centro Nacional de Biotecnologia, CSIC, Ciudad Universitaria Cantoblanco, Madrid, Spain.
6Microbiology and Tumorbiology Centre, Karolinska Institute, Stockholm, Sweden
7Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/j.vaccine.2008.03.083

10.1089/aid.1997.13.1487

10.1089/088922299310313

10.1016/S1359-6446(01)02081-5

10.1159/000067919

10.1056/NEJM199501263320401

Chakrabarti S, 1997, Biotechniques, 23, 1094, 10.2144/97236st07

Connor RI, 1998, J Virol, 72, 1552, 10.1128/JVI.72.2.1552-1576.1998

10.1093/nar/29.5.e26

10.1128/JVI.75.22.10991-11001.2001

10.1146/annurev.immunol.15.1.617

10.1128/JVI.77.21.11563-11577.2003

10.1093/intimm/14.1.31

10.1089/aid.1995.11.909

10.1093/embo-reports/kve141

10.4049/jimmunol.172.10.6209

10.1016/j.vaccine.2006.11.051

10.1016/j.vaccine.2006.09.090

10.1128/JVI.74.22.10822-10826.2000

10.1089/aid.1998.14.285

10.1146/annurev.immunol.18.1.927

Hanke T, 1999, J Virol, 73, 7524, 10.1128/JVI.73.9.7524-7532.1999

10.1084/jem.20071331

Harrer T, 1996, J Immunol, 156, 2616, 10.4049/jimmunol.156.7.2616

10.1006/viro.2002.1722

10.4049/jimmunol.167.12.7180

10.1126/science.1531159

Hu SL., 1992, J Med Primatol, 21, 119, 10.1111/j.1600-0684.1992.tb00577.x

10.1016/S0264-410X(00)00191-2

10.1016/j.vaccine.2008.02.072

10.1128/JVI.02345-08

10.1128/JVI.02216-07

10.1128/JVI.78.7.3333-3342.2004

10.1016/S0140-6736(96)90401-8

10.1172/JCI118133

10.1016/S0167-5699(00)01612-1

10.1038/nm0195-59

10.1038/nm0498-397

10.1111/j.1600-065X.1999.tb01326.x

10.1128/JVI.76.22.11659-11676.2002

10.1073/pnas.93.18.9571

10.1128/JVI.74.23.11367-11376.2000

Tartaglia J, 1994, Dev Biol Stand, 82, 125

10.1016/0042-6822(92)90752-B

10.1093/nar/18.suppl.2367

10.1089/104303400750038507

Wagner R, 1999, J Immunol, 162, 3727, 10.4049/jimmunol.162.6.3727

10.1016/j.vaccine.2004.01.035

10.1128/JVI.76.17.8690-8701.2002

10.1128/JVI.74.6.2628-2635.2000